RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+9.05%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$661M
AUM Growth
+$661M
(+5.4%)
Cap. Flow
-$9.85M
Cap. Flow
% of AUM
-1.49%
Top 10 Holdings %
Top 10 Hldgs %
25.72%
Holding
101
New
10
Increased
24
Reduced
44
Closed
5
Top Buys
| 1 |
ABMD
Abiomed Inc
ABMD
|
$13M |
| 2 |
Perrigo
PRGO
|
$11.6M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$11.2M |
| 4 |
CVS Health
CVS
|
$8.12M |
| 5 |
Bausch Health
BHC
|
$7.01M |
Top Sells
| 1 |
Amgen
AMGN
|
$8.6M |
| 2 |
Alkermes
ALKS
|
$7.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$6.17M |
| 4 |
Edwards Lifesciences
EW
|
$5.92M |
| 5 |
HCA Healthcare
HCA
|
$5.68M |
Sector Composition
| 1 | Healthcare | 92.69% |
| 2 | Financials | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Lexicon Pharmaceuticals
LXRX
$392M
| – | – |
-200,000
| Closed | -$2.15M |
|